NSG 533 ADVANCED PHARMACOLOGY
FINAL EXAM QUESTIONS 2025/2026 WITH
CORRECT DETAILED ANSWERS ||
ALREADY GRADED A+ <RECENT
VERSION>
Which of the following substances/medications would not be expected to
contribute to panic anxiety?
A. Albuterol
B. Olanzapine
C. Cannabis
D. Phenylephrine
E. Caffeine - ANSWER B
,Pregabalin is a preferred treatment for a patient with GAD and a history of which
of the following?
A. Comorbid depression
B. Alcohol dependence
C. Did not tolerate SSRIs
D. Renal impairment
E. Nonadherence - ANSWER C
The following treatment would be preferred for a 12-year-old with SAD.
A. Alprazolam
B. Fluoxetine
C. Pregabalin
D. Cognitive-behavioral therapy (CBT)
E. Individual supportive psychotherapy - ANSWER D
Which of the following statements is true regarding quetiapine in the treatment of
anxiety disorders?
A. Is effective for treatment of panic disorder
B. Is associated with weight gain, sedation, and fatigue
C. Is effective in doses above 300 mg/day
D. Superior efficacy to SSRIs
E. Similar efficacy to CBT - ANSWER B
Which of the following medications is not an appropriate initial treatment for a 23-
year-old woman with GAD and no other comorbidities?
,A. Pregabalin
B. Quetiapine
C. Sertraline
D. Venlafaxine
E. Fluoxetine - ANSWER B
Which of the following is true of CBT in the treatment of anxiety?
A. Only effective when delivered face to face
B. Is inferior to antidepressants in acute treatment of panic disorder
C. Is associated with more sustainable benefits than antidepressants
D. Is not effective for children with anxiety disorders
E. Is less expensive than medications - ANSWER C
A 23-year-old otherwise healthy woman with GAD has no past history of drug or
alcohol abuse and no family history of substance abuse. She is started on
lorazepam 0.5 mg three times daily. Which of the following side effects will you
warn her about?
a. Risk of withdrawal symptoms upon discontinuation
b. Sedation
c. Anterograde amnesia
d. Slowed reaction time
e. All of the above - ANSWER E
Which initial antidepressant regimen is likely to be the best tolerated by a patient
with panic disorder?
, A. Duloxetine 60 mg daily
B. Bupropion 300 mg XL daily
C. Imipramine 50 mg three times daily
D. Paroxetine 10 mg daily
E. Buspirone 15 mg three times daily - ANSWER D
A 22-year-old woman with SAD has significant improvement in anxiety after 14
weeks of
treatment with sertraline. How long should she remain on sertraline?
A. Discontinue now
B. Additional 3 months
C. Additional 6 months
D. Additional 1-2 years
E. Lifetime therapy - ANSWER C
Pregabalin is a preferred treatment for a patient with GAD and a history of which
of the following?
A. Comorbid depression
B. Alcohol dependence
C. Did not tolerate SSRIs
D. Renal impairment
E. Nonadherence - ANSWER C
FINAL EXAM QUESTIONS 2025/2026 WITH
CORRECT DETAILED ANSWERS ||
ALREADY GRADED A+ <RECENT
VERSION>
Which of the following substances/medications would not be expected to
contribute to panic anxiety?
A. Albuterol
B. Olanzapine
C. Cannabis
D. Phenylephrine
E. Caffeine - ANSWER B
,Pregabalin is a preferred treatment for a patient with GAD and a history of which
of the following?
A. Comorbid depression
B. Alcohol dependence
C. Did not tolerate SSRIs
D. Renal impairment
E. Nonadherence - ANSWER C
The following treatment would be preferred for a 12-year-old with SAD.
A. Alprazolam
B. Fluoxetine
C. Pregabalin
D. Cognitive-behavioral therapy (CBT)
E. Individual supportive psychotherapy - ANSWER D
Which of the following statements is true regarding quetiapine in the treatment of
anxiety disorders?
A. Is effective for treatment of panic disorder
B. Is associated with weight gain, sedation, and fatigue
C. Is effective in doses above 300 mg/day
D. Superior efficacy to SSRIs
E. Similar efficacy to CBT - ANSWER B
Which of the following medications is not an appropriate initial treatment for a 23-
year-old woman with GAD and no other comorbidities?
,A. Pregabalin
B. Quetiapine
C. Sertraline
D. Venlafaxine
E. Fluoxetine - ANSWER B
Which of the following is true of CBT in the treatment of anxiety?
A. Only effective when delivered face to face
B. Is inferior to antidepressants in acute treatment of panic disorder
C. Is associated with more sustainable benefits than antidepressants
D. Is not effective for children with anxiety disorders
E. Is less expensive than medications - ANSWER C
A 23-year-old otherwise healthy woman with GAD has no past history of drug or
alcohol abuse and no family history of substance abuse. She is started on
lorazepam 0.5 mg three times daily. Which of the following side effects will you
warn her about?
a. Risk of withdrawal symptoms upon discontinuation
b. Sedation
c. Anterograde amnesia
d. Slowed reaction time
e. All of the above - ANSWER E
Which initial antidepressant regimen is likely to be the best tolerated by a patient
with panic disorder?
, A. Duloxetine 60 mg daily
B. Bupropion 300 mg XL daily
C. Imipramine 50 mg three times daily
D. Paroxetine 10 mg daily
E. Buspirone 15 mg three times daily - ANSWER D
A 22-year-old woman with SAD has significant improvement in anxiety after 14
weeks of
treatment with sertraline. How long should she remain on sertraline?
A. Discontinue now
B. Additional 3 months
C. Additional 6 months
D. Additional 1-2 years
E. Lifetime therapy - ANSWER C
Pregabalin is a preferred treatment for a patient with GAD and a history of which
of the following?
A. Comorbid depression
B. Alcohol dependence
C. Did not tolerate SSRIs
D. Renal impairment
E. Nonadherence - ANSWER C
